Two Period / Two Treatment Cross-over to Assess the Effect of Florastor® on Gastrointestinal Tolerability, Safety, and PK in Healthy Subjects Receiving Zavesca®

Clinical trial NCT01822028 · COMPLETED

Trial details

NCT number

NCT01822028

Sponsor

Actelion

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2013-03-01

Primary completion

2013-06-01

Enrollment

42

View on ClinicalTrials.gov